Xconomy | National - Business + Technology in the Exponential Economy

Archives

by in
Entry Blogger Date  ▴ Xconomist Location
Illumina Shows its Stuff to Wall Street, Stock Still Slides Luke Timmerman 11/07/08 San Diego
Tysabri’s Roots at the “Hutch,” MediQuest Spurned by FDA, ZymoGenetics Drug Passes Test, & More Seattle-Area Life Sciences News Luke Timmerman 11/06/08 Seattle
Tysabri: The Big Multiple Sclerosis Drug That Emerged From “The Hutch” Luke Timmerman 11/04/08 Seattle
Democratic Party Fundraiser Dies, After Friends and Family Pushed To Get Him Tysabri Luke Timmerman 10/31/08 Boston
Biogen Idec, Elan’s Tysabri Linked to First U.S. Case of Brain Infection Luke Timmerman 10/29/08 Boston
Allozyne Advances Toward Clinic, Sonosite Boots CFO, Leroy Hood’s Common Thread With Tupac, & More Seattle-Area Life Sciences News Luke Timmerman 10/17/08 Seattle
Allozyne, Developer of Multiple Sclerosis Drug in Fewer Shots, Poised to Enter Clinical Trials Luke Timmerman 10/16/08 Seattle
Biogen Turns Down Dying Patient’s Request For Tysabri—and Explains Why Luke Timmerman 10/14/08 Boston
Leroy Hood, Turning 70, Still Aims to Accomplish “The Most Ambitious Things of My Career” Luke Timmerman 10/10/08 Seattle
Biogen Idec, Elan Start First Cancer Trial With Tysabri Luke Timmerman 09/05/08 Boston
ZymoGenetics Hands Over Atacicept Rights to Partner, Merck KGaA Luke Timmerman 09/03/08 Seattle
Biogen Idec Testing Regenerative Medicine Drug to Reverse the Path of Multiple Sclerosis Luke Timmerman 08/27/08 Boston
FDA Doesn’t Appear Overly Alarmed by Recent Cases of Brain Disease Associated With Tysabri; Working with Biogen Idec and Elan to Update Labeling Luke Timmerman 08/26/08 Boston
Taligen CEO Aims to Develop Drugs For Inflammatory Diseases, Build Company in Cambridge Luke Timmerman 08/14/08 Boston
Novo Nordisk Returning to Seattle, Hiring 80 People by 2010 Luke Timmerman 08/05/08 Seattle
Biogen Idec, Elan Shares Plummet on News of Two PML Cases With Tysabri Luke Timmerman 08/01/08 Boston
Biogen Idec, Elan Report Two New Cases of Rare Brain Infection in Tysabri Patients Luke Timmerman 07/31/08 Boston
Biogen Idec, Elan Say More Than 31,800 Patients Taking Tysabri For MS Luke Timmerman 07/22/08 Boston
Biogen Idec Isn’t Sweating Possible Sale of Genentech to Roche Luke Timmerman 07/22/08 Boston
Genzyme Reaching For a Slice From Biogen’s Breadbasket, Multiple Sclerosis Drugs Luke Timmerman 07/17/08 Boston
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.